Skip to content
Menu

Kyverna Therapeutics, Inc. KYTX

Full chart Compare
Set alert

Price alert · KYTX

All alert types
4.37 USD -0.11 (-2.46%)

Regular-session close

4.89 +0.52 +12.00%

After hours · Nov 19, 4:00 PM ET

4.30 Day range 4.62
4.30 52-week range 13.67
YTD
-53.51%
1 year
-46.90%

Revenue & Expenses

Revenue Profit Costs
Other Income$491.00KGross Profit$7.03MNet Loss$28.89MExpenses$36.41MSelling, General & Admin$8.01MResearch & Development$28.40MRevenue$7.03M

Latest period ending Dec 31, 2025 · select a line to chart its full history

KYTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-169.83M-142.60M-62.41M-29.38M-26.35M
-161.31M-127.48M-60.37M-28.89M-26.35M
-3.64-3.33-89.61-63.43-99.10
KYTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
124.64M97.17M35.21M38.29M76.62M
293.83M304.64M75.19M66.92M85.49M
61.55M38.06M26.02M20.25M23.02M
29.03M8.24M9.08M10.56M5.55M
232.28M266.59M-131.40M-74.00M-46.25M
KYTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-153.71M-114.25M-52.41M-36.11M-22.16M
40.02M-160.90M-8.79M-14.10M-1.29M
141.17M337.11M58.12M11.88M72.52M
-1.06M-2.21M-621.00K-768.00K-1.29M
27.47M61.96M-3.08M-38.33M49.08M